Abstract Library

#557 The Role of Chemotherapy in the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The Large Experience of the Spanish National Tumor Registry (RGETNE)

Introduction: GEPNETs represent a heterogenous family of tumors of challenging clinical management. Treatment of advanced disease is evolving, including some recent relevant achievements with novel targeted agents. How to best integrate these new agents with conventional chemotherapy(CT) is still a matter of debate.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Garcia-Carbonero R, Capdevila J, Jimenez-Fonseca P, Alonso V, Pachon V,

Keywords: chemotherapy,

#293 99mTc Labelled GLP-1 Scintigraphy with Use of [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4 in the Diagnosis of Insulinoma

Introduction: GLP-1-receptor scanning offers a new approach for successful localization of small insulinomas or those that are undetectable by other methods.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Sowa-Staszczak A, Pach D, Tomaszuk M, Stefanska A, Jabrocka A,

Keywords: [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4, insulinomas,

#290 Peptide Receptor Radiotherapy as a Potential Tool of Neoadjuvant Therapy in Patients with Inoperable Neuroendocrine Tumors (NETs)

Introduction: Neoadjuvant treatment is used as pre-surgical therapy in different cancers to decrease tumor size. PRRT can be a useful tool in neoadjuvant treatment of patients with well-differentiated NETs.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Sowa-Staszczak A, Pach D, Stefanska A, Tomaszuk M, Mikolajczak R,

Keywords: neoadjuvant therapy, PRRT, NET,